Journal article
Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model
Nature genetics, Vol.46(1), pp.24-32
01/2014
DOI: 10.1038/ng.2847
PMCID: PMC4131144
PMID: 24316982
Abstract
The most common risk factor for developing hepatocellular carcinoma (HCC) is chronic infection with hepatitis B virus (HBV). To better understand the evolutionary forces driving HCC, we performed a near-saturating transposon mutagenesis screen in a mouse HBV model of HCC. This screen identified 21 candidate early stage drivers and a very large number (2,860) of candidate later stage drivers that were enriched for genes that are mutated, deregulated or functioning in signaling pathways important for human HCC, with a striking 1,199 genes being linked to cellular metabolic processes. Our study provides a comprehensive overview of the genetic landscape of HCC.
Details
- Title: Subtitle
- Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model
- Creators
- Emilie A Bard-Chapeau - Institute Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Biopolis, SingaporeAnh-Tuan Nguyen - Institute Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Biopolis, SingaporeAlistair G Rust - Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1HH, UKAhmed Sayadi - Institute Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Biopolis, SingaporePhilip Lee - Clinical Imaging Research Centre, National University of Singapore, Centre for Translation Medicine, 14 Medical Drive, #B1-01, 117599, SingaporeBelinda Q Chua - Institute Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Biopolis, SingaporeLee-Sun New - Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, 117543, SingaporeJohann de Jong - Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX AmsterdamJerrold M Ward - Institute Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Biopolis, SingaporeChristopher Ky Chin - Institute Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Biopolis, SingaporeValerie Chew - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (ASTAR), Biopolis, SingaporeHan Chong Toh - National Cancer Centre, SingaporeJean-Pierre Abastado - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (ASTAR), Biopolis, SingaporeTouati Benoukraf - Cancer Science Institute of Singapore, National University of Singapore, Department of Pathology, National University Health System, SingaporeRichie Soong - Cancer Science Institute of Singapore, National University of Singapore, Department of Pathology, National University Health System, SingaporeFrederic A Bard - Institute Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Biopolis, SingaporeAdam J Dupuy - Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA, 52242Randy L Johnson - Department of Biochemistry and Molecular Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USAGeorge K Radda - Clinical Imaging Research Centre, National University of Singapore, Centre for Translation Medicine, 14 Medical Drive, #B1-01, 117599, SingaporeEric Cy Chan - Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, 117543, SingaporeLodewyk Fa Wessels - Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX AmsterdamDavid J Adams - Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1HH, UKNancy A Jenkins - Institute Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Biopolis, SingaporeNeal G Copeland - Institute Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Biopolis, Singapore
- Resource Type
- Journal article
- Publication Details
- Nature genetics, Vol.46(1), pp.24-32
- DOI
- 10.1038/ng.2847
- PMID
- 24316982
- PMCID
- PMC4131144
- NLM abbreviation
- Nat Genet
- ISSN
- 1061-4036
- eISSN
- 1546-1718
- Publisher
- United States
- Grant note
- 13031 / Cancer Research UK Cancer Research UK Wellcome Trust P30 CA016672 / NCI NIH HHS A13031 / Cancer Research UK
- Language
- English
- Date published
- 01/2014
- Academic Unit
- Anatomy and Cell Biology; Pathology
- Record Identifier
- 9984025442902771
Metrics
14 Record Views